title: Weekly epirubicin in patients with hormone refractory prostatic cancer--a two-year follow-up.
authors.affiliation: Farmitalia Carlo Erba GmbH/D-Freiburg.
authors.forename: K
authors.initials: K
authors.lastname: Burk
authors.forename: W
authors.initials: W
authors.lastname: Schultze-Seemann
authors.forename: D
authors.initials: D
authors.lastname: Jonas
authors.forename: G
authors.initials: G
authors.lastname: Rodeck
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000469:Alkaline Phosphatase / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D015251:Epirubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D005500:Follow-Up Studies; D005860:Germany, West; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D013997:Time Factors
chemical_list: D014408:Biomarkers, Tumor; D015251:Epirubicin; D000469:Alkaline Phosphatase